Pascale Lause

1.9k total citations
35 papers, 1.6k citations indexed

About

Pascale Lause is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pascale Lause has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Physiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pascale Lause's work include Muscle Physiology and Disorders (20 papers), Nutrition and Health in Aging (9 papers) and Adipose Tissue and Metabolism (6 papers). Pascale Lause is often cited by papers focused on Muscle Physiology and Disorders (20 papers), Nutrition and Health in Aging (9 papers) and Adipose Tissue and Metabolism (6 papers). Pascale Lause collaborates with scholars based in Belgium, France and United States. Pascale Lause's co-authors include Jean‐Paul Thissen, Olivier Schakman, H. Gilson, Jean‐Marie Ketelslegers, Jean‐Paul Thissen, Mischaël Dehoux, S. Kalista, Audrey Loumaye, Damien Gruson and Kunihiro Tsuchida and has published in prestigious journals such as Nature, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Pascale Lause

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascale Lause Belgium 20 1.1k 662 286 239 146 35 1.6k
Shephali Bhatnagar United States 19 1.2k 1.1× 525 0.8× 195 0.7× 182 0.8× 119 0.8× 23 1.7k
Sarah M. Judge United States 23 1.3k 1.2× 827 1.2× 292 1.0× 361 1.5× 94 0.6× 39 1.8k
Roberta Sartori Italy 19 1.6k 1.5× 899 1.4× 428 1.5× 202 0.8× 129 0.9× 30 2.2k
Scott D. Dufresne United States 17 903 0.8× 562 0.8× 282 1.0× 251 1.1× 82 0.6× 22 1.4k
Angelika Meyer Switzerland 7 1.1k 1.0× 716 1.1× 239 0.8× 102 0.4× 127 0.9× 9 1.6k
Bingwen Jin United States 14 1.2k 1.2× 448 0.7× 191 0.7× 289 1.2× 170 1.2× 17 1.6k
Alessandro Fanzani Italy 22 1.0k 1.0× 494 0.7× 321 1.1× 117 0.5× 68 0.5× 56 1.5k
Estelle Lach‐Trifilieff Switzerland 16 1.2k 1.1× 844 1.3× 264 0.9× 88 0.4× 135 0.9× 19 1.7k
Alan Koncarevic United States 8 892 0.8× 443 0.7× 246 0.9× 230 1.0× 118 0.8× 8 1.1k
Luca Madaro Italy 23 1.2k 1.1× 429 0.6× 156 0.5× 153 0.6× 150 1.0× 46 1.7k

Countries citing papers authored by Pascale Lause

Since Specialization
Citations

This map shows the geographic impact of Pascale Lause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Lause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Lause more than expected).

Fields of papers citing papers by Pascale Lause

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Lause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Lause. The network helps show where Pascale Lause may publish in the future.

Co-authorship network of co-authors of Pascale Lause

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Lause. A scholar is included among the top collaborators of Pascale Lause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Lause. Pascale Lause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barsy, Marie de, et al.. (2024). Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity. Clinical Nutrition. 43(7). 1800–1808. 7 indexed citations
2.
Lause, Pascale, Olivier Schakman, Audrey Loumaye, et al.. (2024). Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour‐bearing mice. Journal of Cachexia Sarcopenia and Muscle. 15(3). 919–933. 5 indexed citations
3.
Canouil, Mickaël, Louise Deldicque, Pascale Lause, et al.. (2023). Identification of myokines susceptible to improve glucose homeostasis after bariatric surgery. European Journal of Endocrinology. 189(3). 409–421. 4 indexed citations
4.
Barbé, Caroline, Audrey Loumaye, Pascale Lause, Olli Ritvos, & Jean‐Paul Thissen. (2021). p21-Activated Kinase 1 Is Permissive for the Skeletal Muscle Hypertrophy Induced by Myostatin Inhibition. Frontiers in Physiology. 12. 677746–677746. 3 indexed citations
5.
Loumaye, Audrey, Marie de Barsy, Maxime Nachit, et al.. (2015). Role of Activin A and Myostatin in Human Cancer Cachexia. The Journal of Clinical Endocrinology & Metabolism. 100(5). 2030–2038. 166 indexed citations
6.
Gruson, Damien, Audrey Ginion, Pascale Lause, et al.. (2012). Urotensin II and urocortin trigger the expression of myostatin, a negative regulator of cardiac growth, in cardiomyocytes. Peptides. 33(2). 351–353. 14 indexed citations
7.
Gruson, Damien, Audrey Ginion, Pascale Lause, et al.. (2011). Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway. Heart and Vessels. 27(2). 202–207. 14 indexed citations
8.
Kalista, S., Olivier Schakman, H. Gilson, et al.. (2011). The Type 1 Insulin-Like Growth Factor Receptor (IGF-IR) Pathway Is Mandatory for the Follistatin-Induced Skeletal Muscle Hypertrophy. Endocrinology. 153(1). 241–253. 45 indexed citations
9.
Gruson, Damien, Audrey Ginion, Pascale Lause, et al.. (2010). Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3β signaling pathway. Peptides. 31(7). 1326–1333. 32 indexed citations
10.
Gilson, H., Olivier Schakman, S. Kalista, et al.. (2009). Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. American Journal of Physiology-Endocrinology and Metabolism. 297(1). E157–E164. 201 indexed citations
11.
Gilson, H., Olivier Schakman, Lydie Combaret, et al.. (2006). Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle Atrophy. Endocrinology. 148(1). 452–460. 225 indexed citations
12.
Dehoux, Mischaël, et al.. (2006). IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3β pathways and inhibition of atrogin-1 mRNA. American Journal of Physiology-Endocrinology and Metabolism. 292(1). E145–E150. 38 indexed citations
13.
Dehoux, Mischaël, Ronald Van Beneden, Pascale Lause, et al.. (2004). Role of the Insulin-Like Growth Factor I Decline in the Induction of Atrogin-1/MAFbx during Fasting and Diabetes. Endocrinology. 145(11). 4806–4812. 120 indexed citations
14.
Motte, Sophie, Ronald Van Beneden, Benoı̂t Rondelet, et al.. (2003). Early activation of cardiac and renal endothelin systems in experimental heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 285(6). H2482–H2491. 25 indexed citations
15.
Dehoux, Mischaël, et al.. (2003). Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Letters. 544(1-3). 214–217. 123 indexed citations
16.
Lause, Pascale, et al.. (2000). In Vitro Effects of Oestradiol on Galanin Gene Expression in Rat Anterior Pituitary Cells. Journal of Neuroendocrinology. 12(6). 559–564. 13 indexed citations
17.
Maiter, Dominique, et al.. (1999). Vascular endothelin-1 is transiently overexpressed in perinephritic hypertension. Digital Access to Libraries. 100(18). 175–175. 1 indexed citations
18.
19.
Ninh, Nguyen Xuan, et al.. (1998). Failure of exogenous IGF-I to restore normal growth in rats submitted to dietary zinc deprivation. Journal of Endocrinology. 159(2). 211–217. 22 indexed citations
20.
Lemaigre, Frédéric P., et al.. (1994). Insulin inhibits glucocorticoid‐induced stimulation of liver 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase gene transcription. FEBS Letters. 340(3). 221–225. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shephali Bhatnagar Breakdown of academic impact, for papers by Sarah M. Judge Breakdown of academic impact, for papers by Roberta Sartori Breakdown of academic impact, for papers by Scott D. Dufresne Breakdown of academic impact, for papers by Angelika Meyer Breakdown of academic impact, for papers by Bingwen Jin Breakdown of academic impact, for papers by Alessandro Fanzani Breakdown of academic impact, for papers by Estelle Lach‐Trifilieff Breakdown of academic impact, for papers by Alan Koncarevic Breakdown of academic impact, for papers by Luca Madaro
Rankless by CCL
2026